|
gptkbp:instance_of
|
gptkb:virus
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:End_Polio_Now
gptkb:circulating_vaccine-derived_poliovirus
|
|
gptkbp:caused_by
|
gptkb:poliomyelitis
|
|
gptkbp:community_impact
|
gptkb:healthcare_access
community awareness
disability
stigma
economic burden
|
|
gptkbp:conservation_efforts
|
gptkb:Global_Polio_Eradication_Initiative
|
|
gptkbp:distribution
|
gptkb:Africa
gptkb:Europe
gptkb:Middle_East
gptkb:Asia
gptkb:North_America
|
|
gptkbp:family
|
gptkb:Picornaviridae
|
|
gptkbp:genetic_diversity
|
type 1
type 2
type 3
|
|
gptkbp:genus
|
gptkb:virus
|
|
gptkbp:healthcare
|
high morbidity
high mortality
|
|
gptkbp:historical_significance
|
major public health concern
caused epidemics
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
wild poliovirus
|
|
gptkbp:is_affected_by
|
gptkb:Person
|
|
gptkbp:is_monitored_by
|
environmental sampling
acute flaccid paralysis surveillance
|
|
gptkbp:is_protected_by
|
vaccination
|
|
gptkbp:is_vulnerable_to
|
gptkb:inactivated_polio_vaccine
oral polio vaccine
possible occurrence
|
|
gptkbp:military_strategy
|
routine immunization
supplementary immunization activities
|
|
gptkbp:replaced_by
|
1909
|
|
gptkbp:research_focus
|
genetic studies
vaccine development
pathogenesis studies
immune response studies
|
|
gptkbp:scientific_classification
|
wild poliovirus type 1
wild poliovirus type 2
wild poliovirus type 3
|
|
gptkbp:social_responsibility
|
PCR testing
viral culture
|
|
gptkbp:status
|
endemic in some regions
|
|
gptkbp:symptoms
|
fatigue
headache
nausea
fever
sore throat
muscle weakness
paralysis
|
|
gptkbp:transmission
|
fecal-oral route
|
|
gptkbp:treatment
|
supportive care
antiviral drugs
rehabilitation therapies
|